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ABSTRACT
Objective Valid, reliable critical appraisal tools
advance quality improvement (QI) intervention
impacts by helping stakeholders identify higher
quality studies. QI approaches are diverse and differ
from clinical interventions. Widely used critical
appraisal instruments do not take unique QI
features into account and existing QI tools (eg,
Standards for QI Reporting Excellence) are intended
for publication guidance rather than critical
appraisal. This study developed and
psychometrically tested a critical appraisal
instrument, the QI Minimum Quality Criteria Set
(QI-MQCS) for assessing QI-specific features of QI
publications.
Methods Approaches to developing the tool and
ensuring validity included a literature review,
in-person and online survey expert panel input, and
application to empirical examples. We investigated
psychometric properties in a set of diverse QI
publications (N=54) by analysing reliability
measures and item endorsement rates and
explored sources of disagreement between
reviewers.
Results The QI-MQCS includes 16 content
domains to evaluate QI intervention publications:
Organisational Motivation, Intervention Rationale,
Intervention Description, Organisational
Characteristics, Implementation, Study Design,
Comparator Description, Data Sources, Timing,
Adherence/Fidelity, Health Outcomes,
Organisational Readiness, Penetration/Reach,
Sustainability, Spread and Limitations. Median
inter-rater agreement for QI-MQCS items was κ
0.57 (83% agreement). Item statistics indicated
sufficient ability to differentiate between
publications (median quality criteria met 67%).
Internal consistency measures indicated coherence
without excessive conceptual overlap (absolute
mean interitem correlation=0.19). The critical
appraisal instrument is accompanied by a user
manual detailingWhat to consider,Where to look
and How to rate.
Conclusions We developed a ready-to-use, valid
and reliable critical appraisal instrument applicable
to healthcare QI intervention publications, but
recognise scope for continuing refinement.
INTRODUCTION
Quality improvement (QI) interventions
account for substantial investments by orga-
nisations aiming to improve healthcare
quality, and a large volume of literature
documents these efforts.1 QI research
necessarily reflects work with organisa-
tional context and local environments. QI
interventions tend to be complex, multi-
component, often uniquely tailored to set-
tings, and may evolve over time.1 2
Intervention details, context and informa-
tion on the QI process are critical to evalu-
ate the success of QI interventions.
To address the unique requirements
of QI research, the Standards for QI
Reporting Excellence (SQUIRE) group has
developed detailed guidance for reporting
evaluations of QI interventions.3 The
reporting guideline helps authors describe
QI interventions so that they can be identi-
fied as such in electronic databases. It aims
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to ensure readers can understand and appraise the inter-
vention and its evaluation by identifying for authors the
details they need to report. However, tools are also
needed to guide the critical appraisal of published QI
studies. Critical appraisal assesses the quality of publica-
tions, informs decisions about applicability of results,
and aims to identify high-quality published studies.
While reporting guidelines can be aspirational and com-
prehensive because they are designed for future publica-
tions, critical appraisal tools must be applicable to the
wide range of completed studies and concentrate on key
assessment domains if they are to be useful in practice.
Researchers have frequently questioned the methodo-
logical quality of QI studies.4 However, tools widely
used for the critical appraisal of clinical interventions,
such as the Cochrane Risk of Bias tool,5 may not encom-
pass the domains most relevant to QI research. The lack
of a QI-specific focus can limit the ability of researchers,
practitioners and policy makers to identify—and learn
from—higher quality QI studies.
We have developed the QI Minimum Quality Criteria
Set (QI-MQCS) to appraise the quality of QI-specific
aspects of QI publications. The QI-MQCS is intended as
a resource for reviewers, assisting in synthesising the vast
available evidence on QI interventions, and providing a
framework for critical appraisal in this complex research
area. This article describes the development and evalu-
ation of the QI-MQCS.
METHODS
Our international workgroup of QI and systematic
review experts (subsequently called ‘workgroup’)
followed a structured process to develop and evalu-
ate the QI-MQCS. We used a broad and inclusive
definition of QI interventions to ensure the
QI-MQCS applies to a variety of efforts to change/
improve the clinical structure, process and/or out-
comes of care by means of an organisational or
structural change.
The QI-MQCS reflects core domains developed
through literature review, inputs from QI experts and
stakeholders, and item development through iterative
application to empirical studies. Formal reliability
testing and reviewer guidance were used to enable
consistent and replicable scoring. We designed the
QI-MQCS items to be modest in number to ensure
scoring feasibility, have strong face validity with QI
stakeholders, meet psychometric standards to enable
reliable assessment, avoid repeating internal validity
items from study-design specific appraisal tools and
applicable to a wide range of QI publications.
The following describes the development of the
domains (the content the QI-MQCS aims to cover),
the operationalisation as QI-MQCS items (the con-
crete appraisal questions and scoring criteria), the
available tools and resources (the QI-MQCS form and
manual) and the psychometric evaluation of the
QI-MQCS.
Domain development
To ensure that the QI-MQCS represents the breadth
of relevant domains,6 we first reviewed a wide range
of existing tools. We assessed widely endorsed
general5 7 8 and specific critical appraisal tools;9 report-
ing guidelines for QI and3 10 11 behaviour change inter-
ventions;12 study design-specific guidelines;13 14 relevant
frameworks such as Reach Effectiveness Adoption
Implementation Maintenance;15 and the Medical
Research Council (MRC) Guidance for Complex
Interventions.16 Relevant resources were identified
through a PubMed literature search for critical appraisal
and QI; screening EQUATOR-network.com; critical
appraisal resources provided by the Center for Reviews
and Dissemination, the Evidence-based Practice Center
programme of the Agency for Healthcare Research and
Quality, the Oxford Centre for Evidence Based
Medicine, the National Institute for Health and Care
Excellence, and the Cochrane Effective Practice and
Organisation of Care (EPOC) Review Group; and exist-
ing systematic reviews of critical appraisal and evidence
level hierarchies.17–19 In addition, workgroup members
assessed all 57 SQUIRE items for their relevance to a
critical appraisal instrument. They rated 22 items as
important or very important, for example ‘Describes the
intervention and its component parts in sufficient detail
that others could reproduce it’ and ‘Identifies the study
design chosen for measuring impact of the intervention
on primary and secondary outcomes’, but rated many
other aspects of the reporting guideline as less important
(eg, ‘Title states the specific aim of the intervention’,
‘Discussion relates results to other evidence’).
A consensus panel of international technical experts
and key stakeholders in QI interventions, informed by
the literature review and SQUIRE survey results, estab-
lished the QI-MQCS domains.20 We elicited the input
of this technical expert panel (TEP) through online
surveys and in person meetings.21 The project aim was
to establish a feasible instrument that covers core QI
domains rather than compiling an exhaustive list of
potentially relevant or intervention-specific elements.
An overarching conclusion of the content discussions
was that the QI-MQCS should address domains that
complement, rather than replace, instruments addres-
sing the internal validity of study designs.5
Operationalisation
The workgroup operationalised the domains as a crit-
ical appraisal instrument. Items were iteratively devel-
oped to capture the content of the domains and to
enable reliable scoring of published articles. We
included a domain description (eg, ‘Rationale linking
the intervention to its expected effects’), guide
(eg, ‘Consider citations of theories, logic models, or
existing empirical evidence that link the intervention
to its expected effects’) and minimum standard for
each quality criterion (‘Names or describes a rationale
linking at least one central intervention component to
Research and reporting methodology
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intended effects’). This process involved translating
conceptual constructs (eg, ‘Penetration/Reach’) and
phrases open to interpretation (eg, ‘Intervention and
its component parts described in sufficient detail that
others could reproduce it’) into practical scoring rules
(‘Describes the proportion of all eligible units that
actually participated’; ‘Describes at least one specific
change in detail including the personnel executing the
intervention’). We sought to avoid conceptual overlap,
so that scoring of one domain would not influence
other domain scores. We refined the criteria by apply-
ing them to empirical examples of the literature.
Throughout the process, we held discussions with
key informants and drew upon examples of empirical
literature to define the domains and standards for
published QI evaluations. We sought input from QI
researchers, QI practitioners and systematic reviewers
experienced in QI literature syntheses. We applied all
suggested critical appraisal domains, reviewer guid-
ance and scoring criteria to empirical examples of
existing QI publications to establish the QI-MQCS.
Tools and resources
We designed a form that translates the established
domains into critical appraisal items with a dichotom-
ous answer mode and scoring criteria to help
reviewers decide whether a minimum quality standard
is met. In addition, we adopted the Appraisal of
Guidelines for Research and Evaluation structure22 to
provide detailed guidance for QI-MQCS users. The
Description defines the domain, What to Consider lists
aspects relevant to the domain, Where to Look directs
users to where the information is typically found in
publications and How to Rate guides item scoring.
The guidance provides illustrative article excerpts rele-
vant to each domain.
Psychometric evaluation
To test the psychometric properties of the QI-MQCS,
we used a validated QI search strategy to identify an
empirical sample of diverse published QI and continu-
ous QI intervention studies indexed in PubMed.23
The strategy combined QI and continuous QI, QI
intervention components and EPOC-eligible interven-
tions search terms. We screened the search output to
identify publications evaluating the effects of QI inter-
ventions. We applied our working definition of
QI24 25 by using four broad criteria to select relevant
studies: healthcare delivery organisation context;
reporting data on the effectiveness, impacts or success
of an intervention; reporting patient, caregiver, pro-
vider behaviour, or process of care outcomes; and
interventions aiming to change how delivery of care is
routinely structured. The interventions in the 54
studies included in the QI-MQCS evaluation data set
focused on restructuring of departments and teams,
checklists or audit and feedback to increase preventive
services and performance indicators, shared medical
appointments, pain management programmes, fall
management and restraint prevention programmes,
staff training and education restructuring, hospital
care and diagnostic procedure redesigns, clinical
guidelines, medication management models, incentive
programmes to increase patient access, computerised
registers, discharge planning, antenatal care restructur-
ing, and telehealth.
Two reviewers agreed on the main intervention and
outcome for each publication prior to quality
appraisal; if publications referred to additional publica-
tions on the same study, we obtained them as well.
Studies were reviewed by two independent reviewers
in batches of nine and then reconciled, mirroring a sys-
tematic review process that uses independent reviewers
and reviewer reconciliation to reduce reviewer errors
and bias. In cases where we had to revise items to
incorporate additional guidance, we discarded previ-
ous ratings. Psychometric results shown below reflect
the final version of the QI-MQCS.
We analysed the answer frequency for each item
(item endorsement rate: number of publications
meeting the criterion in the sample) based on ratings
reconciled across two reviewers.26 We measured two
aspects of reliability: rater agreement and internal con-
sistency.27 Agreement was measured through Cohen’s
κ and the per cent agreement of two independent
reviewers before reconciliation. We assessed internal
consistency and conceptual overlap across the
QI-MQCS domains through interitem correlations
across the 16 assessed items, across all assessed publi-
cations, and based on reconciled reviewer ratings (cor-
relating each item score with all other item scores to
quantify the empirical associations between individual
items). Finally we identified sources of disagreement
for each of the assessed publications.
RESULTS
QI-MQCS content
The QI-MQCS addresses the following domains:
Organisational Motivation, Intervention Rationale,
Intervention Description, Organisational Characteristics,
Implementation, Study Design, Comparator, Data
Source, Timing, Adherence/Fidelity, Health Outcomes,
Organisational Readiness, Penetration/Reach,
Sustainability, Spread and Limitations. Table 1 describes
each domain and table 2 shows the TEP’s ratings of the
importance of each domain (face validity).
Organisational Motivation assesses whether the
motivational context of the organisation in which the
intervention was introduced was described; for example
to convey whether a given quality problem—such as
shortcomings in quality of care indicators—was being
addressed. Intervention Rationale assesses whether a
rationale was given that suggests why the intervention
may produce improvements in the outcome (empirical
evidence, theories or logic models).
Research and reporting methodology
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Intervention Description requires a detailed descrip-
tion of the change in the structure or organisation of
healthcare, including personnel involved. QI interven-
tions are diverse and may address changes in care pro-
cesses (eg, use of care managers) or strategies aiming
to change provider behaviour (eg, electronic
reminders), and the content (eg, avoiding catheter-
related blood stream infections), and the means to
achieve the goal (eg, audit and feedback) are often
intertwined. We restricted the definition to permanent
structural or organisational changes, not temporary
activities aiming to develop or introduce the change.
This domain had the highest rating in the assessment
of the domain importance shown in table 2.
Organisational Characteristics assesses whether key
demographics of the setting are described to provide
information that enables readers to assess the general-
isability to their organisation.
Implementation addresses temporary activities used
to introduce the permanent change, for example, staff
education to introduce a new care protocol. The
QI-MQCS focuses here on the introduction of the
intervention into clinical practice, not its development.
Study Design assesses whether the evaluation design
to determine whether the intervention was successful
was identified. Acknowledging that different questions
require different study designs, the quality emphasis is
on outlining the evaluation approach, not on specific
designs or features (eg, randomisation).
Comparator assesses the control condition to which
the intervention is compared, for example, routine care
before the intervention was introduced. We added this
item, most prominently described in the Workgroup for
Intervention Development and Evaluation Research
(WIDER) criteria,12 in response to TEP discussions and
empirical evidence.28 Given that healthcare contexts are
continually evolving, it is important to know whether the
comparison group comprised current ‘state-of-the-art’ or
Table 2 Technical expert panel (TEP) ratings of included QI domains and per cent criterion met
# Domain Panel item
Mean
rating*
% Criterion
met†
1 Organisational motivation Description of the organisational problem/reason or motivation for intervention 2.78 64
2 Intervention rationale Description of rationale linking the intervention to expected effects 2.78 67
3 Intervention Description of specific changes in healthcare delivery organisation/structure 3.00 93
4 Organisational characteristics Description of organisational demographics and basic characteristics 2.89 89
5 Implementation Description of the approach to designing and/or introducing organisational changes 2.89 92
6 Study design Description of study design 2.89 44
7 Comparator n/a n/a 67
8 Data source n/a n/a 67
9 Timing Description of timing (intervention components introduction and evaluation) 2.78 56
10 Adherence/fidelity Description of intervention adherence/fidelity 2.78 47
11 Health outcomes Description of health-related outcomes 2.33 58
12 Organisational readiness Description of organisational readiness for the studied intervention 2.00 84
13 Penetration/reach Description of intervention penetration/reach 2.56 85
14 Sustainability Description of potential for intervention maintenance or sustainability 2.22 83
15 Spread Description of ability to be spread or replicated 2.11 89
16 Limitations Quality of the interpretation of findings 2.56 64
*Members (N=9) of an international TEP assessed independently whether the domain should (score=3), should maybe (score=2) or should not (score=1)
be part of the Quality Improvement Minimum Quality Criteria Set (QI-MQCS). The respondents were instructed that the goal was to identify a minimum
number of core domains; n/a: not applicable, the items were developed as a response to panel input.
†Percentage of publications meeting the criterion in psychometric evaluation sample (total N=54 publications, number of observations ranged from 18 to
45 as only the final item version was included in the analysis).
Table 1 Quality Improvement Minimum Quality Criteria Set
(QI-MQCS) domains
Domain Description
1. Organisational
motivation
Organisational problem, reason or motivation
for the intervention
2. Intervention rationale Rationale linking the intervention to its
expected effects
3. Intervention
description
Change in organisational or provider
behaviour
4. Organisational
characteristics
Demographics or basic characteristics of the
organisation
5. Implementation Temporary activities used to introduce
potentially enduring changes
6. Study design Study design and comparator
7. Comparator Information about comparator care processes
8. Data source Data sources and outcome definition
9. Timing Timing of intervention and evaluation
10. Adherence/fidelity Adherence to the intervention
11. Health outcomes Patient health-related outcomes
12. Organisational
readiness
Barriers and facilitators to readiness
13. Penetration/reach Penetration/reach of the intervention
14. Sustainability Sustainability of the intervention
15. Spread Ability to be spread or replicated
16. Limitations Interpretation of the evaluation
Research and reporting methodology
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poor quality care. Data Source considers how data were
obtained for the evaluation and whether the primary
outcome was defined; conveying what exactly was mea-
sured should avoid a ‘false implicit understanding’ of
terms and definitions24 and is independent from the
study design selected for the evaluation.
Timing addresses the clarity of the timeline in relation
to the evaluation of the intervention, for example, when
a complex change was fully implemented and when
evaluated, in order to determine the follow-up period.
Adherence/fidelity addresses compliance with the inter-
vention. QI interventions can be introduced with enthu-
siasm, but whether personnel actually adhere to them
(eg, a new assessment tool) in busy routine clinical prac-
tice is another matter. Readers need to be able to judge
whether any intervention failure was attributable to the
intervention itself, suboptimal translation in clinical
practice, or a combination of both. Any information on
adherence (including the lack thereof) is acknowledged
in assessing this domain.
Health Outcomes considers whether patient health
outcomes are part of the evaluation. Although an
intervention may result in changes in healthcare pro-
cesses (eg, tests ordered), they may not necessarily
improve patient outcomes. The QI-MQCS acknowl-
edges studies that assess this crucial patient-centered
question. Organisational Readiness refers to the QI
culture and resources present in the organisation,
which helps to assess the transferability of results. The
TEP did not express strong unanimous support for
including this item (table 2).
Penetration/reach assesses what proportion of eli-
gible units participated. This domain requires a
denominator; stating the number of participating sites
without also reporting how many sites were initially
approached or were eligible is not sufficient.
Sustainability addresses whether information on the
sustainability of the intervention is available; including
positive evidence (eg, an extended intervention
period) or acknowledgment that the intervention may
be maintained only with additional resources.
Spread addresses the ability of the intervention to be
spread to or replicated in other settings. The
minimum quality standard is met if the potential or
unsuccessful attempts at spread or positive evidence
of spread (eg, large-scale rollouts) are presented.
Limitation refers to disclosed limitations of the evalu-
ation of the intervention.
Online supplementary appendix 1 shows the
QI-MQCS, a ready-to-use form for critical appraisal.
Online supplementary appendix 2, a user manual
developed for the QI-MQCS, provides detailed infor-
mation on each domain and scoring criteria, including
What to consider, Where to look and How to rate.
Psychometric properties
The item endorsement rates (criterion met) ranged
between 44% and 93% (table 2) with a median rate of
67% indicating that the QI-MQCS items were able to
differentiate between high and low quality studies in an
empirical sample of QI publications. Two items were
endorsed in more than 90% of assessed QI publications
(Intervention Description and Implementation).
The median inter-rater agreement between two
independent reviewers across all items was κ=0.52
and 82% agreement (table 3). Coefficients ranged
from κ=0.09 (Adherence/fidelity) to κ=0.82
(Sustainability) with corresponding per cent agree-
ment values of 56% and 74%. Agreement for 81% of
items was fair to good; the items Timing, Adherence/
fidelity and Spread were below κ=0.40. Sources of
disagreements between reviewers are documented
in table 4 and encompassed omissions (ie, a reviewer
overlooked reported information), the interpretation
of the reported information (eg, associated with
disagreements in Adherence/fidelity) and the
interpretation of criteria (ie, sufficient to meet the
criterion).
The mean interitem correlation across all QI-MQCS
items in the empirical sample of QI publications was
0.08 (mean absolute interitem correlation 0.19) and
all individual interitem correlations were below 0.67.
Results indicated conceptual independence between
criteria (discriminant validity); items showed some
coherence but not identity of assessed domains.
Correlations of 0.61 to 0.66 were found for the
domains Intervention Description and Data source,
Implementation and Organisational Readiness, and
Data Source correlated with Penetration/Reach as well
as Limitations.
Table 3 Inter-rater agreement Quality Improvement Minimum
Quality Criteria Set (QI-MQCS)
# Domain n κ (95% CI)
%
agreement
1 Organisational
motivation
45 0.46 (0.19 to 0.73) 0.76
2 Intervention rationale 18 0.61 (0.21 to 1.00) 0.83
3 Intervention 27 0.65 (0.02 to 1.28) 0.96
4 Organisational
characteristics
45 0.49 (0.17 to 0.82) 0.84
5 Implementation 36 0.62 (0.23 to 1.01) 0.92
6 Study design 45 0.73 (0.53 to 0.93) 0.87
7 Comparator description 54 0.40 (0.14 to 0.65) 0.72
8 Data source 18 0.87 (0.62 to 1.12) 0.94
9 Timing 54 0.39 (0.15 to 0.63) 0.70
10 Adherence/fidelity 36 0.09 (−0.22 to 0.40) 0.56
11 Health-related outcomes 45 0.64 (0.42 to 0.87) 0.82
12 Organisational readiness 45 0.45 (0.14 to 0.76) 0.82
13 Penetration/reach 27 0.52 (0.18 to 0.85) 0.81
14 Sustainability 18 0.82 (0.49 to 1.15) 0.94
15 Spread 27 0.13 (−0.23 to 0.48) 0.67
16 Limitations 45 0.77 (0.58 to 0.96) 0.89
κ, Cohen’s κ; n, Number of assessed publications.
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DISCUSSION
The QI-MQCS is a critical appraisal instrument that
assesses 16 expert-endorsed QI domains applicable to
a wide range of QI studies. Its scoring guidance facili-
tates use by different raters with known psychometric
properties. A structured critical appraisal instrument
development process ensured feasibility, validity and
reliability.
The QI-MQCS development included a comprehen-
sive literature search to ensure content validity and
iterative development of the operationalisation of
domains applied to existing, published QI literature to
ensure construct validity. The empirical test of the
QI-MQCS shows sufficient ability to discriminate
between studies, indicating that the QI-MQCS avoids
items representing unattainable standards but includes
items that discriminate quality across an empirical
sample of publications. Furthermore, the QI-MQCS
does not show excessive conceptual overlap across
domains, and none of the items shows redundancy
with content already captured through other items.
Agreement between two independent reviewers was
fair to good in a diverse sample of a complex research
field.
Despite the careful, iterative development of items
and scoring criteria, some domains showed limited
rater agreement, such as adherence/fidelity and
spread. Future work is warranted to test the reliability
in a narrower set of interventions, for example, those
included in typical systematic reviews, or to develop
the criteria further in order to achieve better consen-
sus. However, the QI-MQCS compared favourably to
some other commonly used tools, such as the
Cochrane Risk of Bias tool.29 Plus, few published
Table 4 Sources of reviewer disagreements
Source of
disagreement Source description Literature examples
Omissions Some disagreements were associated with simple reviewer
mistakes, that is, one reviewer overlooking reported
information
Several disagreements were simply due to one reviewer
overlooking reported information and did not seem to follow
any pattern (random errors). However, the low agreement in the
Spread domain seemed to have, in parts, to do with
information being ‘buried’ in the discussion section
Omission-based disagreement was also encountered repeatedly
for the domain Organisational characteristics, due to
information not being reported in the main manuscript text but
elsewhere, for example in the author’s biography32
Interpretation of
reported information
Some disagreements were associated with the interpretation
of the information that was reported in the publication
The low agreement in the domain Adherence/fidelity was to
some extent associated with publications where adherence was
the main outcome or the outcome and the intervention were
identical (eg, guideline implementation to improve adherence to
evidence-based practices)33
A further example was whether reviewers considered a
state-wide initiative sufficient to infer the motivation to
participate for all included hospitals.34 Multiple site studies
often do not provide information on individual facilities35 and
studies in low-income countries may have had an initiating
body that was not a healthcare delivery organisation36 and
reviewers disagreed to which extent they extrapolated from the
presented information to individual organisations
Disagreements in the Health Outcome domain were associated
with the type of outcome and how systematically data were
collected in order to be recognised as a health outcome/data37
Interpretation of
criteria
Despite the careful, iterative development of the tool, some
disagreements were associated with the interpretation of the
scoring criteria. Given the large scope of interventions
included in the test set, some ambiguities could not be
resolved
Identified disagreement in the domain Intervention Rationale
was associated with publications where only highly selective
intervention components were linked to existing empirical
literature and reviewers disagreed whether the specific aspect
was sufficient to meet the criterion38
Disagreements in the Comparator domain were associated with
the question of how much detail was considered sufficient to
meet the quality criterion, for example, if only a component of
the usual care was described34
Disagreements also occurred when publications described a
structural change without information on the uptake, for
example, an installation of a comfort room for patients—but
whether the room was used in clinical practice was not
reported; hence reviewers had to decide whether the
intervention was the installation of the room or the use of the
room39
Examples taken from validation sample (N=54 publications), rater agreement is documented in table 3.
Mistakes (omissions) as well as remaining ambiguity (interpretation of reported information and interpretation of criteria) were sources of disagreement
between literature reviewers. A qualitative analysis of the disagreements pointed to some systematic, rather than random, reviewer errors.
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quality assessment tools have been tested for their psy-
chometric properties.17 Reviewer disagreements may
be easier to anticipate and to avoid in a more
restricted sample, for example, one that is limited to a
set of selected QI interventions.
QI stakeholders agree on the pressing need for
better research and better literature synthesis
methods. The QI-MQCS was developed to support
evidence synthesis by providing a critical appraisal
tool to identify high quality QI studies, for example,
in the context of a systematic review. It is designed to
be applicable to a wide range of QI studies.
Developing critical appraisal criteria for QI publica-
tions is challenging due to the diversity of QI inter-
ventions, interdisciplinary language and study designs.
Consequently, the QI-MQCS assesses, for example,
whether the rationale specified for the intervention
links to the study’s main outcome, without dictating
which type of rationale (eg, which evidence-based
intervention or theory) may be superior, given that
this determination may depend on the specific inter-
ventions in this particular field of research. To ensure
wide applicability, we purposefully applied the
QI-MQCS to a diverse set of QI publications in the
psychometric evaluation and did not limit the sample
to specific clinical conditions, QI interventions, out-
comes or study designs.
The QI-MQCS targets the informational value of
the QI study, giving credit to publications that assess
and provide information on crucial variables. Thus,
for example, a publication that reports limited adher-
ence to an intervention or describes that the spread of
the intervention was unsuccessful receives credit for
reporting on adherence and spread. Reviewers may
want to highlight positive expressions of the domain,
for example, evidence of adherence indicating that the
intervention took place as outlined. In this case, the
QI-MQCS can be used as a framework for a more
refined assessment. The specific standards will depend
on the individual field of application.
We designed the QI-MQCS to determine the
minimum quality threshold of core QI domains. QI
experts selected and prioritised domains in order to
establish a feasible critical appraisal instrument.
Furthermore, we developed detailed scoring criteria in
an iterative process to ensure reliability. The assessment
must rely on the information presented in the publica-
tion, and reliable scoring requires clear guidance that
cannot be based on guessing or inside knowledge of
individual reviewers. Nevertheless, reporting short-
comings may not necessarily indicate the absence of
the process in the conduct of the study (eg, the publica-
tion’s word limits may have precluded a full descrip-
tion of the methods) and the psychometric evaluation
distinguished only whether the domain criteria were
met or not. Using the QI-MQCS and its assessment
domains as a framework may allow reviewers to
further differentiate study quality by creating response
options for partially met criteria; by differentiating
unmet criteria into ‘unclear’ and ‘low quality,’ or by
defining criteria for exceptionally high quality studies.
Further differentiation and moving away from the
dichotomy of minimum criteria met or not may also
provide a resolution for some of the described dis-
agreements between reviewers. Additional or alterna-
tive criteria, for example criteria capturing other
aspects of QI interventions3 building on the QI-MQCS
may be important in specific research contexts.
The QI-MQCS was explicitly designed to comple-
ment, not to replace, critical appraisal instruments
focusing on the internal validity of study designs.
Other tools that may be helpful to reviewers are the
EPOC group criteria for randomised controlled
trials, controlled trials and controlled before-after
studies;30 the quality criteria for programme evalua-
tions,31 and a published critical appraisal instrument
for Plan-Do-Study-Act QI.9 Fan et al4 provide a hier-
archy of methodological strength to evaluate a body
of evidence for QI interventions.
The QI-MQCS facilitates access to the vast available
literature on QI interventions by identifying high
quality studies, for example in the context of a system-
atic review aiming to synthesise the available evidence
for specific interventions or outcomes, and provides a
framework for critical appraisal in this complex
research area. It is accompanied by a ready-to-use
standardised quality assessment form and a detailed
user manual. However, we have deliberately titled the
tool V.1.0, expecting that its use will lead to further
refinement and improvements.
CONCLUSIONS
We developed a ready-to-use, valid and reliable critical
appraisal instrument applicable to a wide range of
healthcare QI intervention evaluation publications,
but recognise scope for continuing refinement.
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